US5174930A
(en)
*
|
1986-12-31 |
1992-12-29 |
Centre National De La Recherche Scientifique (Cnrs) |
Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions
|
JP2666345B2
(ja)
*
|
1987-04-16 |
1997-10-22 |
武田薬品工業株式会社 |
リポソーム製剤およびその製造法
|
JPH03502574A
(ja)
*
|
1987-12-03 |
1991-06-13 |
ザ リポソーム カンパニー,インコーポレイテッド |
メチルセルロース製薬学的組成物
|
CA1335348C
(en)
*
|
1988-03-04 |
1995-04-25 |
Yasuaki Ogawa |
Liposome composition
|
JPH01238537A
(ja)
*
|
1988-03-18 |
1989-09-22 |
Toyo Jozo Co Ltd |
肝障害治療剤
|
JPH01246225A
(ja)
*
|
1988-03-28 |
1989-10-02 |
Toyo Jozo Co Ltd |
膵炎治療剤
|
JPH0262829A
(ja)
*
|
1988-05-18 |
1990-03-02 |
Nippon Kayaku Co Ltd |
虚血に基づく傷害の予防及び治療剤
|
US4975541A
(en)
*
|
1988-06-21 |
1990-12-04 |
Burnam Michael H |
Aminoglycosides for controlled drug release
|
EP0440742B1
(en)
*
|
1988-10-27 |
1997-01-15 |
The Regents Of The University Of Minnesota |
Liposome immunoadjuvants containing il-2
|
US5049392A
(en)
*
|
1989-01-18 |
1991-09-17 |
The Liposome Company, Inc. |
Osmotically dependent vesicles
|
US4976968A
(en)
*
|
1989-02-24 |
1990-12-11 |
Clinical Technologies Associates, Inc. |
Anhydrous delivery systems for pharmacological agents
|
US4983402A
(en)
*
|
1989-02-24 |
1991-01-08 |
Clinical Technologies Associates, Inc. |
Orally administerable ANF
|
US4963364A
(en)
*
|
1989-04-10 |
1990-10-16 |
Fox Sidney W |
Microencapsulated antitumor agent
|
FR2653015B1
(fr)
*
|
1989-10-12 |
1993-10-29 |
Oreal |
Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
|
IT1240353B
(it)
*
|
1990-03-30 |
1993-12-07 |
Poli Ind Chimica Spa |
Formulazioni liposomiali di farmaci immunomodulatori per applicazionelocale ed aerosolica
|
WO1991016040A1
(en)
*
|
1990-04-18 |
1991-10-31 |
Takeda Chemical Industries, Ltd. |
Liposome composition
|
US5147652A
(en)
*
|
1990-07-03 |
1992-09-15 |
Cell Research Corporation |
Autobiotics and their use in eliminating nonself cells in vivo
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5714167A
(en)
*
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5443841A
(en)
*
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US6099856A
(en)
*
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5447728A
(en)
*
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5620703A
(en)
*
|
1991-10-11 |
1997-04-15 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Stimulating hematopoietic activity with carboplatin or lobaplatin
|
ATE171071T1
(de)
*
|
1991-12-31 |
1998-10-15 |
Zymogenetics Inc |
Verfahren und zusammensetzungen zur verminderung von blutverlust
|
US5792451A
(en)
*
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5811127A
(en)
*
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5401516A
(en)
*
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US5709861A
(en)
*
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5958457A
(en)
*
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
ES2163444T3
(es)
*
|
1993-04-22 |
2002-02-01 |
Emisphere Tech Inc |
Composiciones y metodos para la administracion oral de farmacos.
|
US6610329B2
(en)
*
|
1993-04-22 |
2003-08-26 |
Emisphere Technologies Inc. |
Compositions for the delivery of antigens
|
US5643957A
(en)
*
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5965121A
(en)
*
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5650386A
(en)
*
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5989539A
(en)
*
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
*
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
*
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
BR9604880A
(pt)
*
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
WO1997036480A1
(en)
|
1996-03-29 |
1997-10-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
*
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US6051258A
(en)
*
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5667806A
(en)
*
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
WO1997010197A1
(en)
*
|
1995-09-11 |
1997-03-20 |
Emisphere Technologies, Inc. |
METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES
|
CA2258264A1
(en)
|
1996-06-14 |
1997-12-18 |
Emisphere Technologies, Inc. |
Microencapsulated fragrances and method for preparation
|
US5804688A
(en)
*
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
*
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
*
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5939381A
(en)
*
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
*
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5990166A
(en)
*
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5863944A
(en)
*
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
*
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
EP1003531B1
(en)
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
IL135060A
(en)
*
|
1997-09-18 |
2005-12-18 |
Skyepharma Inc |
Sustained release liposomal anesthetic compositions and methods for the preparation thereof
|
EP1030652B1
(en)
|
1997-11-14 |
2012-04-25 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
WO1999027964A1
(en)
*
|
1997-12-01 |
1999-06-10 |
Cfy Biomedicals, Inc. |
Multivalent recombinant antibodies for treating hrv infections
|
CA2326348C
(en)
*
|
1998-03-31 |
2009-10-06 |
Yissum Research Development Company Of The Hebrew University In Jerusalem |
Liposomal bupivacaine compositions and methods of preparation
|
DE69940735D1
(de)
|
1998-07-17 |
2009-05-28 |
Pacira Pharmaceuticals Inc |
Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
|
US20030035798A1
(en)
*
|
2000-08-16 |
2003-02-20 |
Fang Fang |
Humanized antibodies
|
US7335646B2
(en)
|
2000-03-13 |
2008-02-26 |
Engene, Inc. |
Compositions and methods for regulated protein expression in gut
|
US20040102388A1
(en)
*
|
2000-03-22 |
2004-05-27 |
High Katherine A. |
Modified blood clotting factors and methods of use
|
US20030185878A1
(en)
*
|
2000-06-23 |
2003-10-02 |
Tetsuo Hoshino |
Process for producing phospholipid-containing drug
|
EP1395243A2
(en)
*
|
2001-05-31 |
2004-03-10 |
SkyePharma Inc. |
Encapsulation of nanosuspensions in liposomes and microspheres
|
AU2002365196C1
(en)
|
2001-07-19 |
2009-08-13 |
Perlan Therapeutics, Inc. |
Multimeric proteins and methods of making and using same
|
EP1448165B1
(en)
*
|
2001-11-13 |
2007-09-19 |
Celator Pharmaceuticals, Inc. |
Lipid carrier compositions and methods for improved drug retention
|
DE60231549D1
(de)
|
2001-12-03 |
2009-04-23 |
Dor Biopharma Inc |
Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
|
WO2004043363A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Azaya Therapeutics, Inc. |
Protein-stabilized liposomal formulations of pharmaceutical agents
|
TWI461436B
(zh)
|
2005-11-25 |
2014-11-21 |
Kyowa Hakko Kirin Co Ltd |
人類cd134(ox40)之人類單株抗體及其製造及使用方法
|
EP1795540A1
(en)
|
2005-11-30 |
2007-06-13 |
Imaxio |
Multimeric complexes of antigens and an adjuvant
|
US20070248539A1
(en)
*
|
2006-04-24 |
2007-10-25 |
Shantha West Inc. |
AgRM2 antigen
|
WO2008152446A2
(en)
|
2006-11-27 |
2008-12-18 |
Patrys Limited |
Novel glycosylated peptide target in neoplastic cells
|
EP2187869B1
(en)
*
|
2007-08-17 |
2015-10-14 |
Celator Pharmaceuticals, Inc. |
Improved platinum drug formulations
|
US8647623B2
(en)
|
2009-04-10 |
2014-02-11 |
Kyowa Hakko Kirin Co., Ltd |
Method for treatment of blood tumor using anti-TIM-3 antibody
|
WO2010126066A1
(ja)
|
2009-04-27 |
2010-11-04 |
協和発酵キリン株式会社 |
血液腫瘍治療を目的とした抗IL-3Rα抗体
|
DK177532B1
(en)
*
|
2009-09-17 |
2013-09-08 |
Bio Bedst Aps |
Medical use of sPLA2 hydrolysable liposomes
|
US9556272B2
(en)
|
2009-11-11 |
2017-01-31 |
The Trustees Of The University Of Pennsylvania |
Anti-TEM1 antibodies and uses thereof
|
WO2013162748A1
(en)
|
2012-04-27 |
2013-10-31 |
The Trustees Of The University Of Pennsylvania |
Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
|
US9790269B2
(en)
|
2013-02-08 |
2017-10-17 |
Misfolding Diagnostics, Inc. |
Transthyretin antibodies and uses thereof
|
WO2014210142A1
(en)
|
2013-06-25 |
2014-12-31 |
Temple University-Of The Commonwealth System Of Higher Education |
Cortical bone-derived stem cells
|
CN104906586A
(zh)
*
|
2014-03-10 |
2015-09-16 |
中国科学院上海药物研究所 |
一种盐酸伊立替康复合磷脂组合物、制备方法及其应用
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|